These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30113683)

  • 1. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
    Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
    Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
    Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study.
    Köhler A; Sarkis AL; Heinrich DA; Müller L; Handgriff L; Deniz S; Schneider H; Künzel H; Ladurner R; Reincke M; Adolf C
    Eur J Endocrinol; 2021 Oct; 185(5):663-672. PubMed ID: 34468397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
    Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
    J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
    J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
    Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.
    Morimoto R; Kudo M; Murakami O; Takase K; Ishidoya S; Nakamura Y; Ishibashi T; Takahashi S; Arai Y; Suzuki T; Sasano H; Ito S; Satoh F
    J Hum Hypertens; 2011 Feb; 25(2):114-21. PubMed ID: 20463748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.
    Lin YH; Huang KH; Lee JK; Wang SM; Yen RF; Wu VC; Chung SD; Liu KL; Chueh SC; Lin LY; Ho YL; Chen MF; Wu KD;
    J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):48-53. PubMed ID: 20719880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
    Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Hashimoto H; Takaeko Y; Harada T; Yamaji T; Han Y; Kihara Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP levels in patients with primary hyperaldosteronism and autonomous cortisol cosecretion.
    Hirsch A; Adolf C; Stüfchen I; Beuschlein F; Brüdgam D; Bidlingmaier M; Reincke M; Quinkler M
    Eur J Endocrinol; 2024 Sep; 191(4):444-456. PubMed ID: 39343731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.